Skip to main content

Asia-Pacific stocks set for mixed start as investors weigh J&J Covid vaccine setback

The U.S. FDA on Tuesday asked states to temporarily halt using Johnson and Johnson's Covid-19 vaccine after six people developed a rare blood-clotting disorder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.